We suggest potential drugs for these plasma proteins, particularly PLG activators, such as Urokinase, Reteplase, Streptokinase, Alteplase, Anistreplase, Tenecteplase, Desmoteplase, and Defibrotide sodium, as potential therapeutic drugs for treating comorbid MI and AF. Here, PLAT is linked to atrial fibrillation.